Covalon Technologies Ltd.
COV.VTSXVHealthcare● Active
$2.16
+$0.06(+2.86%)
Market Cap$59655046
P/E Ratio—
52W High$3.1
52W Low$1.55
Covalon Technologies Ltd. (COV.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · COV.V · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $32.82M | $31.17M | $26.60M | $18.15M | $19.56M |
| Cost of Revenue | $15.34M | $12.24M | $12.23M | $10.65M | $9.86M |
| Gross Profit | $17.47M | $18.93M | $14.36M | $7.49M | $9.70M |
| Gross Margin %(computed) | 53.24% | 60.74% | 54.00% | 41.29% | 49.57% |
| Operating Expenses | |||||
| R&D Expenses | $1.32M | $1.59M | $1.37M | $1.10M | $1.14M |
| G&A Expenses | $7.67M | $7.78M | $7.40M | $6.96M | $4.80M |
| Total Operating Expenses | $15.71M | $16.78M | $14.36M | $16.64M | $8.86M |
| Operating Income | $1.76M | $2.15M | ($4.49M) | ($9.14M) | $0.84M |
| Operating Margin %(computed) | 5.37% | 6.90% | -16.88% | -50.38% | 4.29% |
| Interest Income | $0.44M | $0.00M | $0.07M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.09M | $0.00M | $0.11M | $0.42M |
| Income Before Tax | $2.06M | $2.67M | ($4.46M) | ($9.25M) | $0.42M |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $2.06M | $2.67M | ($4.46M) | ($9.66M) | $23.48M |
| Net Margin %(computed) | 6.27% | 8.57% | -16.77% | -53.25% | 120.02% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.08 | $0.11 | $-0.18 | $-0.38 | $0.08 |
| Wtd Avg Shares | 27.41M | 24.27M | 24.78M | 25.76M | 25.82M |
| EBITDA | $3.01M | $3.14M | ($3.56M) | ($8.11M) | $1.54M |
| EBITDA Margin %(computed) | 9.18% | 10.07% | -13.38% | -44.69% | 7.87% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Covalon Technologies Ltd. data
About Covalon Technologies Ltd. (COV.V) Income Statement
Covalon Technologies Ltd. (COV.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, COV.V reported revenue of $0.03B, gross profit of $0.02B (gross margin 53.24%), and net income of $0.00B — a net profit margin of 6.27%.
Frequently asked questions
COV.V · 4 questionsCovalon Technologies Ltd. (COV.V) reported revenue of $0.03B for 2025, up 5.3% year-over-year.
COV.V revenueCOV.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09